The impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors

被引:5
|
作者
Mohammad, Rima A. [1 ]
Eze, Chinwe [1 ]
Marshall, Vincent D. [1 ]
Coe, Antoinette B. [1 ]
Costa, Deena Kelly [2 ,3 ]
Thompson, Amy [1 ]
Pitcher, Mari [4 ,5 ]
Haezebrouck, Evan [6 ]
McSparron, Jakob I. [7 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Clin Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA
[4] Michigan Med, Ann Arbor, MI USA
[5] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA
[6] Michigan Med, Dept Phys Therapy, Ann Arbor, MI USA
[7] Univ Michigan, Dept Internal Med, Med Sch, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
critical illness; intensive care unit; intensive care unit recovery clinic; medication-related problems; pharmacist; post-intensive care syndrome; ICU; MEDICATIONS; MANAGEMENT; DISCHARGE;
D O I
10.1002/jac5.1671
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Intensive care unit (ICU) survivors are vulnerable to further health deterioration and medication-related problems (MRPs) with a high rate of potentially preventable hospital readmissions and late death. Therefore, it is critical to identify MRPs of ICU survivors post-hospitalization. ICU-recovery clinics (ICU-RCs) have been proposed as a potential mechanism to address the unmet needs of ICU survivors, and pharmacists should be key members of ICU-RCs. Objectives The objective of this study was to evaluate the impact of a pharmacist in an interprofessional ICU-RC on MRPs. Methods A retrospective cohort study was conducted in adult ICU survivors with sepsis/septic shock and/or respiratory failure. This study compared MRPs within 6 months of post-hospital discharge between intervention and control groups. The intervention group included patients who were seen by a pharmacist in an ICU-RC. MRPs and interventions between initial and 6-month follow-up visits in the intervention group were also evaluated. Results Data were collected for 52 control and 52 intervention patients. There were no significant differences in baseline demographics and hospital characteristics between groups. Eighty-four MRPs were identified in the control vs 110 in the intervention group (P = .37). Half of patients in control and intervention groups had at least one MRP identified (P = .69). There was a significant decrease in mean number of MRPs at the 6-month follow-up visit (3.5 +/- 1.7 with initial vs 2.4 +/- 1.3 with follow-up visit; P = .025) in the intervention group. Almost all patients in initial and follow-up visits had at least one MRP. Conclusions Dedicated ICU-RC pharmacists in an interprofessional ICU-RC can assist with addressing and intervening on MRPs which could further impact clinical outcomes in ICU survivors.
引用
收藏
页码:1027 / 1038
页数:12
相关论文
共 50 条
  • [1] Impact of clinical pharmacist in an Indian Intensive Care Unit
    Hisham, Mohamed
    Sivakumar, Mudalipalayam N.
    Veerasekar, Ganesh
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2016, 20 (02) : 78 - 83
  • [2] PHARMACIST INTERVENTIONS IN A POST-INTENSIVE CARE UNIT RECOVERY CLINIC
    Torbic, Heather
    Conroy, Grace
    Ward, Jessica
    Biehl, Michelle
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 421 - 421
  • [3] Impact of a pediatric clinical pharmacist in the pediatric intensive care unit
    Krupicka, MI
    Bratton, SL
    Sonnenthal, K
    Goldstein, B
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (04) : 919 - 921
  • [4] IMPACT OF A CLINICAL PHARMACIST IN A MULTIDISCIPLINARY INTENSIVE-CARE UNIT
    MONTAZERI, M
    COOK, DJ
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (06) : 1044 - 1048
  • [5] Impact of clinical pharmacist on quality of care and cost containment in the intensive care unit (ICU).
    Kim, KS
    Schiller, L
    Menon, L
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (12) : A108 - A108
  • [6] The Role of the Pharmacist in the Intensive Care Unit
    Jurado, Lesly V.
    Steelman, Joshua D.
    [J]. CRITICAL CARE NURSING QUARTERLY, 2013, 36 (04) : 407 - 414
  • [7] Impact of a pharmacist in an interdisciplinary post-cardiac intensive care unit clinic
    Adie, Sarah K.
    Thompson, Amy N.
    Konerman, Matthew C.
    Shea, Michael J.
    Thomas, Michael P.
    Thompson, Andrea D.
    [J]. HEART & LUNG, 2022, 52 : 48 - 51
  • [8] The Impact of Clinical Pharmacist on the Medicine Expenditure in the Surgical Intensive Care Unit
    Lin, Pei-Tzu
    Tai, Ching-Ling
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 475 - 475
  • [9] The impact of clinical pharmacist in a cardiac-surgery intensive care unit
    Al-Jazairi, Abdulrazaq S.
    Al-Agil, Amala.
    Asiri, Yousif A.
    Al-Kholi, Tariq A.
    Akhras, Nathem S.
    Horanieh, Bashar K.
    [J]. SAUDI MEDICAL JOURNAL, 2008, 29 (02) : 277 - 281
  • [10] Clinical Pharmacist Impact on Intensive Care Unit Delirium: Intervention and Monitoring
    Lightfoot, Myaa
    Sanders, Adam
    Burke, Christopher
    Patton, Jessica
    [J]. HOSPITAL PHARMACY, 2019, 54 (03) : 180 - 185